AROA BIOSURGERY LIMITED — Director's Dealing 2021

Feb 22, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	John Diddams
Date of last notice	10 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

be disclosed in this part.
Direct or indirect interest		Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Whitfield Investments Pty Ltd Diddams Family Trust> (Beneficiary) Galdarn Pty Ltd (Beneficiary)
Date of change		22 February 2021
No. of securities held prior to change		Indirect Whitfield Investments Pty Ltd_Diddams Family Trust> 798,675 Fully Paid Ordinary Share 330,000 Options exercisable at $0.1075 expiring 30 November 2029. Galdarn Pty Ltd 213,875 Fully Paid Ordinary Shares
Class		Ordinary Fully Paid Shares
Number acquired		-
Number disposed		200,000

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$238,680.00
No. of securities held after change		Indirect Whitfield Investments Pty Ltd_Diddams Family Trust> 598,675 Fully Paid Ordinary Share 330,000 Options exercisable at $0.1075 expiring 30 November 2029. Galdarn Pty Ltd 213,875 Fully Paid Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder (if issued securities)	-
Date of change	-
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	-
Interest acquired	-
Interest disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	-
Interest after change	-

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date N/A was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011